OrbiMed Capital GP VII LLC
- SEC CIK
- 0001760648
In the past year, 2 open-market purchase filings worth $36.1M and 2 sale filings worth $51.7M.
Current role at each company
- ADRX ADARx Pharmaceuticals, Inc.Director, 10% Owneras of Sep 30, 2026
- ETRA Electra Therapeutics, Inc.Director, 10% Owneras of Sep 23, 2026
- ELVN Enliven Therapeutics, Inc.10% Owneras of Jun 24, 2026
- QTTB Q32 Bio Inc.Director, 10% Owneras of Jun 1, 2026
- KROS Keros Therapeutics, Inc.Directoras of Dec 18, 2025
Show 12 more companies
- PASG Passage BIO, Inc.10% Owneras of Jun 26, 2025
- MBX MBX Biosciences, Inc.Director, 10% Owneras of Feb 19, 2025
- Lomond Therapeutics Holdings, Inc.Directoras of Nov 5, 2024
- TERN Terns Pharmaceuticals, Inc.Director, 10% Owneras of Jul 17, 2024
- KNTE Kinnate Biopharma Inc.Director, 10% Owneras of Apr 5, 2024
- THRX Theseus Pharmaceuticals, Inc.Director, 10% Owneras of Feb 14, 2024
- DMRA Damora Therapeutics, Inc.10% Owneras of Aug 17, 2023
- THRD Third Harmonic Bio, Inc.Director, 10% Owneras of Sep 21, 2022
- SRRA Sierra Oncology, Inc.Director, 10% Owneras of Jul 1, 2022
- ARQT Arcutis Biotherapeutics, Inc.10% Owneras of Jun 28, 2022
- JANX Janux Therapeutics, Inc.Directoras of Dec 17, 2021
- RPTX Repare Therapeutics Inc.Directoras of Sep 8, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $36.1M
- 2 filings
- Sold
- $51.7M
- 2 filings
- Net
- −$15.5M
- Bought minus sold
- Companies
- 3
- With open-market trades
Trades
Every Form 4 that lists OrbiMed Capital GP VII LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ADRX ADARx Pharmaceuticals, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 (view filing)5:23 PM ET | Sep 28 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +950.0K | $17.00 | +$16.1M | New position588.2K after | 3 lots |
ETRA Electra Therapeutics, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 (view filing)5:29 PM ET | Sep 21 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.33M | $15.00 | +$20.0M | +313.8%1.76M after | 2 lots |
ELVN Enliven Therapeutics, Inc.
10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2021 (view filing)4:27 PM ET | Jul 16 | Same day | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.67M | $6.00 | +$10.0M | New position1.67M after | |
| Jul 23, 2021 (view filing)5:30 PM ET | Jul 16 | 7 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | PPurchase | +1.67M | $6.00 | +$10.0M | +65.8%4.20M after | AmendedDuplicate filing |
| May 20, 2024 (view filing)5:00 PM ET | May 16 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | SSale | −1.03M | $22.14 | −$22.9M | −11.9%7.66M after | 2 lotsDuplicate filing |
| Jun 17, 2026 (view filing)7:45 PM ET | Jun 15 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −281.4K | $45.02 | −$12.7M | −3.7%7.39M after | 2 lots |
| Jun 24, 2026 (view filing)7:19 PM ET | Jun 22 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −860.1K | $45.36 | −$39.0M | −11.6%6.56M after | 4 lots |
QTTB Q32 Bio Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 (view filing)9:13 PM ET | May 28 | 4 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +1.88M | $8.00 | +$15.0M | New position625.0K after | 2 lotsDuplicate filing |
PASG Passage BIO, Inc.
10% Owner15 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2022 (view filing)7:37 PM ET | Jan 11-13 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +150.0K | $5.61 | +$841.1K | +2.5%6.10M after | 3 lots |
| Jan 20, 2022 (view filing)6:03 PM ET | Jan 14-19 | 6 daysLate | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +168.3K | $5.38 | +$905.2K | +2.8%6.27M after | 3 lots |
| May 5, 2022 (view filing)5:11 PM ET | Jan 20 | 105 days | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +50.8K | $5.00 | +$254.0K | +0.8%6.32M after | Amended |
| May 5, 2022 (view filing)5:23 PM ET | May 3-4 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +525.0K | $1.94 | +$1.02M | +8.3%6.84M after | 2 lots |
| Jun 29, 2023 (view filing)4:42 PM ET | Jun 27-28 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | PPurchase | +1.19M | $0.84 | +$1.00M | +17.4%8.03M after | 2 lots |
| Sep 18, 2024 (view filing)6:38 PM ET | Sep 16-18 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −200.1K | $0.7332 | −$146.7K | −2.5%7.83M after | 3 lots |
| Sep 23, 2024 (view filing)4:51 PM ET | Sep 19 | 4 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −39.3K | $0.71 | −$27.9K | −0.5%7.79M after | |
| Dec 6, 2024 (view filing)7:07 PM ET | Dec 4-6 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −97.1K | $0.7965 | −$77.3K | −1.2%7.70M after | 2 lots |
| Dec 11, 2024 (view filing)5:32 PM ET | Dec 9-11 | 2 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −62.3K | $0.8348 | −$52.0K | −0.8%7.64M after | 3 lots |
| Dec 26, 2024 (view filing)4:34 PM ET | Dec 20 | 6 days | OrbiMed Advisors LLC and 1 other10% Owner | SSale | −230.3K | $0.60 | −$138.2K | −3.0%7.40M after |
MBX MBX Biosciences, Inc.
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2024 (view filing)8:13 PM ET | Sep 16 | 1 day | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +750.0K | $16.00 | +$12.0M | New position653.8K after | 2 lotsDuplicate filing |
| Feb 19, 2025 (view filing)5:52 PM ET | Feb 14-18 | 5 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +190.7K | $10.60 | +$2.02M | +34.2%747.9K after | 4 lotsDuplicate filing |
KROS Keros Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2024 (view filing)5:01 PM ET | Aug 13 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −250.0K | $44.01 | −$11.0M | −67.7%119.5K after | 2 lotsDuplicate filing |
TERN Terns Pharmaceuticals, Inc.
Director, 10% Owner4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2022 (view filing)5:00 PM ET | Aug 16 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +3.69M | $2.42 | +$8.93M | New position762.4K after | 3 lotsDuplicate filing |
| Aug 18, 2022 (view filing)5:00 PM ET | Aug 16 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +310.0K | – | – | –64.0K after | Derivative3 lotsDuplicate filing |
| Dec 28, 2022 (view filing)5:57 PM ET | Dec 23 | 5 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | PPurchase | +137.9K | $7.25 | +$1.00M | +2.9%4.88M after | Duplicate filing |
| Jul 17, 2024 (view filing)8:48 PM ET | Jul 15-16 | 2 days | OrbiMed Advisors LLC and 4 othersDirector, 10% Owner | SSale | −56.2K | $10.00 | −$561.6K | −6.9%755.6K after | 6 lots10b5-1Duplicate filing |
DMRA Damora Therapeutics, Inc.
10% Owner7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 7, 2023 (view filing)4:42 PM ET | Apr 5-6 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −102.6K | $2.16 | −$222.0K | −3.9%2.51M after | 6 lots |
| Apr 12, 2023 (view filing)6:44 PM ET | Apr 10-12 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −67.5K | $1.80 | −$121.4K | −2.7%2.46M after | 9 lots |
| Apr 17, 2023 (view filing)5:28 PM ET | Apr 13-17 | 4 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −68.5K | $1.87 | −$128.3K | −2.8%2.42M after | 9 lots |
| Jul 17, 2023 (view filing)4:13 PM ET | Jul 13 | 4 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −194.7K | $2.40 | −$467.3K | −7.8%2.29M after | 3 lots |
| Jul 27, 2023 (view filing)4:28 PM ET | Jul 25 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −39.2K | $2.92 | −$114.5K | −1.7%2.26M after | 3 lots |
| Aug 2, 2023 (view filing)5:05 PM ET | Jul 31 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −209.4K | $3.00 | −$628.2K | −9.0%2.11M after | 3 lots |
| Aug 17, 2023 (view filing)4:40 PM ET | Aug 15 | 2 days | OrbiMed Advisors LLC and 4 others10% Owner | SSale | −822.7K | $0.75 | −$617.0K | −35.3%1.51M after | 3 lots |
THRX Theseus Pharmaceuticals, Inc.
Director, 10% Owner5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2021 (view filing)5:00 PM ET | Oct 12 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +625.0K | $16.00 | +$10.0M | New position499.1K after | 2 lotsDuplicate filing |
| Jan 13, 2022 (view filing)7:18 PM ET | Jan 11-13 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +44.7K | $9.90 | +$442.8K | +0.3%16.4M after | 4 lotsDuplicate filing |
| Jan 21, 2022 (view filing)7:18 PM ET | Jan 19-21 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +158.4K | $9.97 | +$1.58M | +1.0%16.5M after | 3 lotsDuplicate filing |
| Nov 9, 2022 (view filing)4:25 PM ET | Nov 7 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +192.0K | $5.21 | +$1.00M | +1.2%16.7M after | Duplicate filing |
| Jul 19, 2023 (view filing)4:15 PM ET | Jul 17 | 2 days | OrbiMed Advisors LLC and 2 othersDirector, 10% Owner | PPurchase | +479.9K | $3.05 | +$1.46M | +281.2%650.6K after | 2 lotsDuplicate filing |
KNTE Kinnate Biopharma Inc.
Director, 10% Owner3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2022 (view filing)9:42 PM ET | Feb 11-15 | 4 days | OrbiMed Advisors LLC and 3 othersDirector | PPurchase | +195.7K | $10.17 | +$1.99M | +5.9%3.51M after | 4 lotsDuplicate filing |
| May 2, 2023 (view filing)9:34 PM ET | Apr 28-May 2 | 4 days | OrbiMed Advisors LLC and 6 othersDirector, 10% Owner | PPurchase | +1.41M | $2.61 | +$3.67M | New position794.4K after | 9 lotsDuplicate filing |
| May 8, 2023 (view filing)5:22 PM ET | May 4-5 | 4 days | OrbiMed Advisors LLC and 6 othersDirector, 10% Owner | PPurchase | +1.46M | $2.80 | +$4.09M | New position1.37M after | 5 lotsDuplicate filing |
THRD Third Harmonic Bio, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2022 (view filing)6:00 PM ET | Sep 19 | 2 days | OrbiMed Advisors LLC and 1 otherDirector, 10% Owner | PPurchase | +300.0K | $17.00 | +$5.10M | +5.5%5.78M after | Duplicate filing |
ARQT Arcutis Biotherapeutics, Inc.
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2022 (view filing)6:06 PM ET | Apr 6-8 | 2 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −878.2K | $20.68 | −$18.2M | −66.1%451.1K after | 6 lots |
| Jun 28, 2022 (view filing)4:29 PM ET | Jun 24 | 4 days | OrbiMed Advisors LLC and 2 others10% Owner | SSale | −342.0K | $21.31 | −$7.29M | −45.2%415.1K after | 2 lots |
JANX Janux Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2021 (view filing)5:13 PM ET | Dec 16 | 1 day | OrbiMed Advisors LLC and 2 othersDirector | SSale | −393.3K | $19.07 | −$7.50M | −61.5%245.9K after | 2 lotsDuplicate filing |
RPTX Repare Therapeutics Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2021 (view filing)8:55 PM ET | Aug 17-18 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −20.3K | $34.10 | −$693.2K | −17.1%98.6K after | 4 lotsDuplicate filing |
| Aug 25, 2021 (view filing)8:43 PM ET | Aug 23-25 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −18.2K | $34.17 | −$622.4K | −15.7%98.1K after | 6 lotsDuplicate filing |
| Aug 30, 2021 (view filing)6:37 PM ET | Aug 26-30 | 4 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −18.1K | $34.07 | −$615.7K | −15.6%97.5K after | 6 lotsDuplicate filing |
| Sep 2, 2021 (view filing)8:27 PM ET | Aug 31-Sep 2 | 2 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −37.9K | $34.08 | −$1.29M | −28.2%96.4K after | 6 lotsDuplicate filing |
| Sep 8, 2021 (view filing)6:18 PM ET | Sep 3-7 | 5 days | OrbiMed Advisors LLC and 2 othersDirector | SSale | −8.08K | $33.99 | −$274.8K | −7.8%96.2K after | 4 lotsDuplicate filing |